Type 1 DiabetesNCT07212530
EmoTIChealth: Promoting Adolescent Health Through a Serious Game.
A study testing EmoTIChealth in people with Type 1 Diabetes and Asthma, run by University of Valencia at 1 site in Spain.
Trial summary
The intervention program targets adolescents between 12 and 16 years of age. The intervention program is designed for adolescents during a critical developmental stage marked by significant life transitions, where building strong personal resources and receiving psychological support is essential to foster… Read more about this study
- Who is it for?
- Ages 12 to 16 yearsHealthy volunteers can take part
- Conditions the study is for
- Type 1 Diabetes, Asthma, Allergic Rhinitis
- What is being tested?
- EmoTIChealth
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 600 participants
- Where
- 1 siteSpain
- Study dates
- 1 Dec 2025to 30 Aug 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 16 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Informed consent by parents/guardians and participants.
- Aged between 12 and 16 years old
Who cannot join
- No access to internet or new technologies
- Not a Spanish speaker.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Spain1 site, 1 recruiting
- Recruiting
Facultat de Psicología
Valencia, Valencia, 46010
Marián Pérez-Marín, PHD, 0034 9639 ext. 83392, marian.perez@uv.es
Selene Valero-Moreno, PHD
About this study
Official title: "Promoting Health in Adolescents With and Without Chronic Diseases Through Emotional Development: Design and Implementation of a Serious Game Technology Platform (EmoTIChealth)"
The intervention program targets adolescents between 12 and 16 years of age. The intervention program is designed for adolescents during a critical developmental stage marked by significant life transitions, where building strong personal resources and receiving psychological support is essential to foster socioemotional skills and overall well-being. The serious game aims to promote psycho-emotional health in the general adolescent population, supporting healthy development and preventing future emotional difficulties. At the same time, it incorporates specific modules for adolescents living with chronic conditions such as asthma, food allergy, type 1 diabetes, and allergic rhinitis, who may face additional risks of psychological challenges that can complicate treatment and prognosis. By combining universal health promotion with tailored support, the program addresses both the needs of healthy adolescents and those with chronic illnesses.
The platform integrates digital and technological tools for dynamic and personalized intervention. Artificial intelligence adapts activities and feedback to each participant's socio-demographic profile and evolving needs, this supports directly in participants' daily lives and natural environments, making the experience more relevant and impactful. The serious game, proven effective in engaging young people, goes beyond traditional psychoeducation by creating an interactive environment where adolescents develop socio-emotional competencies, resilience, and health-related knowledge. Through its six thematic areas, the game promotes overall well-being and healthy habits, while its condition-specific modules provide targeted guidance and coping strategies for asthma, food allergies, type 1 diabetes, and allergic rhinitis.
- Conditions
- Type 1 Diabetes, Asthma, Allergic Rhinitis, Food Allergy, Adolescent Development
- Being tested
- EmoTIChealth
- Keywords
- Type 1 Diabetes, Asthma, Allergic Rhinitis, Food allergy, Serious Game, Technology platform, Psychological intervention, Adolescence, Quality of life, chronic organic illnesses, Socioemotional Education, Health Promotion
- Medical subject headings
- Diabetes Mellitus, Type 1, Asthma, Rhinitis, Allergic, Food Hypersensitivity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EmoTIChealthBehavioural
The EmoTIChealth technological platform intervenes in users through a "serious game", i.e. a video game whose main purpose is to teach or provide the player with certain skills that serve to achieve a higher purpose than the game itself. The game is composed of 6 areas, each of which refers to one of the variables that are analyzed or considered important in promoting health related quality of life and adaptation to chronic illness: Area 1. Psychoeducation; 2. Emotional awareness and expression; 3. Emotional regulation; 4. Problem solving; 5. Self-esteem and identity;6. Social skills and communication.
| Study group | Role | What they receive |
|---|---|---|
| Experimental group | Experimental | Adolescents who receive the treatment program will previously constitute their own control group (waiting list control group). Thus, diagnostic measures will be obtained in all of them in an initial evaluation (T1), and after 4 weeks of this assessment the treatment program will be started. In the first contact session, 4 weeks after T1, all adolescents will be reassessed (T2), and after this, the treatment program will be started (within an estimated time of 10 days maximum from this second pre-treatment evaluation, the estimated duration of play/treatment being 4 weeks). After the completion of the serious game, a new asssesment pass will be performed (T3) in order to review the post-treatment change. Thus, the estimated time between T2 and T3 will be equivalent to that between T1 and T2, being 4 weeks. Receives: Behavioral: EmoTIChealth |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change Quality of Life (Baseline-Pre-Post)
KIDSCREEN-27. This scale consists of 27 items in 5 subscales. Physical well-being, mood, family life, school life, peer relations. Scores range from 27 to 135. Higher scores indicate a higher quality of life in general and in each of the subscales.
First measurement: After the participant had signed the informed consent, the initial score for this outcome was assessed.
Second measurement: PRE- Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out.
Third measurement: POST Up to 4 weeks after the second measurement, the third measurement of the same variable was carried out. [Time Frame: Baseline up to 8 weeks]
Measured: Baseline up to 8 weeks
Change Emotional and Behavioral Problems (Baseline-Pre-Post)
SDQ: This questionnaire is used to assess the possible presence of psychopathology and the emotional and behavioral adjustment of adolescents. It is a 25-item Likert-type (1-3) questionnaire. The items of this questionnaire are divided into 5 subscales: emotional symptomatology, conduct problems, hyperactivity, peer problems and prosocial behavior. Higher scores on each scale indicate greater difficulties.
First measurement: After the participant had signed the informed consent, the initial score for this outcome was assessed.
Second measurement: PRE- Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out.
Third measurement: POST Up to 4 weeks after the second measurement, the third measurement of the same variable was carried out.
Measured: Baseline up to 8 weeks
Change Emotional Competences (Baseline-Pre-Post)
EAQ-30: This questionnaire consists of 30 Likert-style items (1-False to 3-True), and aims to identify how adolescents think about their feelings, as well as the degree to which they feel them and the ability to express them. In addition to an overall score, this tool is composed of 6 subscales that attempt to describe different aspects of emotional functioning. Higher scores indicate greater use of emotional awareness and regulation strategies.
First measurement: After the participant had signed the informed consent, the initial score for this outcome was assessed.
Second measurement: PRE- Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out.
Third measurement: POST Up to 4 weeks after the second measurement, the third measurement of the same variable was carried out.
Measured: Baseline up to 8 weeks
Change Self-concept (Baseline-Pre-Post)
CAG: This questionnaire aims to measure self-concept in adolescents from a multidimensional perspective. It consists of 48 Likert-type response items ranging from 1 to 5, providing a score range of 48 to 240. Physical Self-Concept, Social Acceptance, Family Self-Concept, Intellectual Self-Concept, Personal Self-Assessment, and Sense of Control. The questionnaire provides an overall self-concept score, as well as scores for 6 subdimensions: Higher scores indicate higher self-concept.
This is the first measurement. After obtaining the participant's informed consent, we assessed the initial score for this outcome.
The second measurement, labeled PRE, was conducted up to 4 weeks after the first measurement of the same variable.
The third measurement, labeled POST, was carried out up to 4 weeks after the second measurement.
Measured: Baseline up to 8 weeks
Change Coping (Baseline-Pre-Post)
Social Problem-Solving Inventory- Revised (SPSI-R). This questionnaire attempts to reflect the cognitive, affective and behavioral responses to the problems of daily life or the different difficulties we try to solve. This reduced version consists of 25 Likert-type items, grouped into the following 5 dimensions: Rational problem solving, Avoidant style, Impulsive style, Positive problem orientation and Negative problem orientation. Higher scores on each dimension signify the coping style used by the adolescent.
First measurement: After the participant had signed the informed consent, the initial score for this outcome was assessed.
Second measurement: PRE- Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out.
Third measurement: POST Up to 4 weeks after the second measurement, the third measurement of the same variable was carried out.
Measured: Baseline up to 8 weeks
Change Social Skills (Baseline-Pre-Post)
CHASO: It consists of 40 Likert-type response items ranging from 1 to 5 (1 - Very uncharacteristic of me; 5 - Very characteristic of me) and assesses a total of 10 skills: 1. Interacting with strangers; 2. Dealing with criticism; 4. Interacting with people I am attracted to; 5. Staying calm in the face of criticism; 6. Public speaking/interacting with superiors; 7. The scores for each of these skills are calculated from the sum of the items that make them up. Higher scores indicate higher social skills.
First measurement: After the participant had signed the informed consent, the initial score for this outcome was assessed.
Second measurement: PRE- Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out.
Third measurement: POST Up to 4 weeks after the second measurement, the third measurement of the same variablewas carried out.
Measured: Baseline up to 8 weeks
Secondary outcomes (5)
Change in Perception of Threat of disease(Baseline-Pre-Post)
The Brief Illness Threat Questionnaire (BIP-Q) is used, which consists of 5 items with a Likert scale from 0 to 10. This questionnaire mainly assesses consequences of the illness, duration of the illness, identity, worry about the illness and emotional impact of the illness. The scale is interpreted so that the higher the score, the greater the sense of perceived threat.
First measurement: After the participant had signed the informed consent, the initial score for this outcome was assessed.
Second measurement: PRE- Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out.
Third measurement: POST Up to 6 weeks after the second measurement, the third measurement of the same variable was carried out.
Measured: Baseline up to 8 weeks
Change Psychoeducation Diabetes
Psychoeducation of the disease: the ECODI Diabetes knowledge scale will be used to assess this variable. This scale consists of 25 items and four dimensions: basic knowledge and self-care, laboratory values, diet and physical exercise. It is a scale that is corrected by the number of hits and misses. Psychoeducation about the disease: The ECODI diabetes knowledge scale is used to assess this variable. This scale consists of 25 items and four dimensions: basic knowledge and self-care, laboratory values, diet and exercise. It is a scale that is corrected by the number of hits and misses.
Measured: Start of the intervetion and during it.
Change Resilience (Baseline-Pre-Post)
Connor-Davidson Resilience Scale to assess the ability to cope with stress and adversity. The resilience scale is made up of 10 items, with a range of scores from 0 to 40, with higher scores indicating greater resilience.
First measurement: Once the participant had signed the informed consent, the initial score for this outcome was assessed.
Second measurement: PRE- Up to 4 weeks after the first measurement the second measurement of the same variable was carried out.
Third measurement: POST Up to 4 weeks after the second measurement the third measurement of the same variable was carried out.
Measured: Baseline up to 8 weeks
Outcome Measure: Change in Perceived Importance of Health Habits (Baseline-Pre-Post)
A self-report questionnaire specifically developed for this study will be used to assess adolescents' perceived importance of maintaining healthy habits. The instrument consists of 16 Likert-type items (1 = Not important at all to 5 = Extremely important) that evaluate three domains:
- Nutrition (e.g., balanced diet, regular meal patterns).
- Hygiene (e.g., daily personal hygiene routines).
- Physical exercise (e.g., regular engagement in physical activity).
- Healthy sleep habits (e.g. sleeping at least 8 hours, having a defined schedule.) Higher scores indicate greater perceived importance attributed to healthy behaviors across the three domains, with a total score ranging from 16 to 80. Subscale scores will also be calculated for each domain.
First measurement (T1): Baseline, after informed consent. Second measurement (T2): Approximately 4 weeks after baseline (pre-intervention re-assessment).
Third measurement (T3): Approximately 4 weeks after T2 (post-intervention assessment)
Measured: Baseline up to 8 weeks
Outcome Measure: Assessment of the intervention and change in the emotional state of the participants
These items aim to assess the intervention from the perspective of adolescents, specifically in terms of the extent to which it has helped them in different areas of their daily lives. There will be a total of 13 Likert-type items ranging from 0 (it has not helped me at all) to 10 (it has helped me a lot). These items will only be collected at the final time point (T3), i.e. after the intervention has been completed.
The degree of difficulty experienced in their lives and their emotional state will also be evaluated using six Likert scale items ranging from 0 to 10. Information on these difficulties and emotional state assessments will be collected at the three assessment points (T1, T2 and T3).
First measurement (T1): Baseline, after informed consent. Second measurement (T2): Approximately 4 weeks after baseline (pre-intervention re-assessment).
Third measurement (T3): Approximately 4 weeks after T2 (post-intervention assessment).
Measured: Baseline up to 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2025
- Study start1 Dec 2025
- Primary completion30 Aug 2027 (estimated)
- Study completion30 Aug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Type 1 DiabetesStudies of the same condition, open and under way.
- More trials run by University of ValenciaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 600 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Valencia
- Sponsor type
- University, hospital or other
- Collaborators
- Universitat Politècnica de València
- Responsible party
- Principal investigator, M. Antonia Pérez-Marín, University of Valencia
- Investigators
- Marián Pérez-Marín, PHD, Principal investigator, Universitat de Valencia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07212530
- Sponsor's protocol ID
- EmoTIChealth
- Status last verified
- May 2026
- First submitted
- 30 Sep 2025
- Last updated
- 13 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- "Promoting Health in Adolescents With and Without Chronic Diseases Through Emotional Development: Design and Implementation of a Serious Game Technology Platform (EmoTIChealth)"
- ClinicalTrials.gov ID
- NCT07212530
- Acronym / sponsor ID
- EmoTIChealth
- Conditions
- Type 1 Diabetes, Asthma, Allergic Rhinitis, Food Allergy, Adolescent Development
- Keywords
- Type 1 Diabetes, Asthma, Allergic Rhinitis, Food allergy, Serious Game, Technology platform, Psychological intervention, Adolescence
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 600 participants (estimated)
- Lead sponsor
- University of ValenciaUniversity, hospital or other
- Collaborators
- Universitat Politècnica de València
- Study start
- 1 Dec 2025 (actual)
- Primary completion
- 30 Aug 2027 (estimated)
- Study completion
- 30 Aug 2027 (estimated)
- First posted
- 8 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The intervention program targets adolescents between 12 and 16 years of age. The intervention program is designed for adolescents during a critical developmental stage marked by significant life transitions, where building strong personal resources and receiving psychological support is essential to foster socioemotional skills and overall well-being. The serious game aims to promote psycho-emotional health in the general adolescent population, supporting healthy development and preventing future emotional difficulties. At the same time, it incorporates specific modules for adolescents living with chronic conditions such as asthma, food allergy, type 1 diabetes, and allergic rhinitis, who may face additional risks of psychological challenges that can complicate treatment and prognosis. By combining universal health promotion with tailored support, the program addresses both the needs of healthy adolescents and those with chronic illnesses.
The platform integrates digital and technological tools for dynamic and personalized intervention. Artificial intelligence adapts activities and feedback to each participant's socio-demographic profile and evolving needs, this supports directly in participants' daily lives and natural environments, making the experience more relevant and impactful. The serious game, proven effective in engaging young people, goes beyond traditional psychoeducation by creating an interactive environment where adolescents develop socio-emotional competencies, resilience, and health-related knowledge. Through its six thematic areas, the game promotes overall well-being and healthy habits, while its condition-specific modules provide targeted guidance and coping strategies for asthma, food allergies, type 1 diabetes, and allergic rhinitis.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Experimental group | Experimental | Behavioral: EmoTIChealthAdolescents who receive the treatment program will previously constitute their own control group (waiting list control group). Thus, diagnostic measures will be obtained in all of them in an initial evaluation (T1), and after 4 weeks of this assessment the treatment program will be started. In the first contact session, 4 weeks after T1, all adolescents will be reassessed (T2), and after this, the treatment program will be started (within an estimated time of 10 days maximum from this second pre-treatment evaluation, the estimated duration of play/treatment being 4 weeks). After the completion of the serious game, a new asssesment pass will be performed (T3) in order to review the post-treatment change. Thus, the estimated time between T2 and T3 will be equivalent to that between T1 and T2, being 4 weeks. |
Who may qualify
- Ages
- 12 to 16 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (2 listed)
- Informed consent by parents/guardians and participants.
- Aged between 12 and 16 years old
Key exclusion criteria (2 listed)
- No access to internet or new technologies
- Not a Spanish speaker.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EmoTIChealthThe EmoTIChealth technological platform intervenes in users through a "serious game", i.e. a video game whose main purpose is to teach or provide the player with certain skills that serve to achieve a higher purpose than the game itself. The game is composed of 6 areas, each of which refers to one of the variables that are analyzed or considered important in promoting health related quality of life and adaptation to chronic illness: Area 1. Psychoeducation; 2. Emotional awareness and expression; 3. Emotional regulation; 4. Problem solving; 5. Self-esteem and identity;6. Social skills and communication. | Behavioural | Experimental group |
Primary outcome
Change Quality of Life (Baseline-Pre-Post)
Time frame: Baseline up to 8 weeks
KIDSCREEN-27. This scale consists of 27 items in 5 subscales. Physical well-being, mood, family life, school life, peer relations. Scores range from 27 to 135. Higher scores indicate a higher quality of life in general and in each of the subscales. First measurement: After the participant had signed the informed consent, the initial score for this outcome was assessed. Second measurement: PRE- Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out. Third measurement: POST Up to 4 weeks after the second measurement, the third measurement of the same variable was carried out. [Time Frame: Baseline up to 8 weeks]
Change Emotional and Behavioral Problems (Baseline-Pre-Post)
Time frame: Baseline up to 8 weeks
SDQ: This questionnaire is used to assess the possible presence of psychopathology and the emotional and behavioral adjustment of adolescents. It is a 25-item Likert-type (1-3) questionnaire. The items of this questionnaire are divided into 5 subscales: emotional symptomatology, conduct problems, hyperactivity, peer problems and prosocial behavior. Higher scores on each scale indicate greater difficulties. First measurement: After the participant had signed the informed consent, the initial score for this outcome was assessed. Second measurement: PRE- Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out. Third measurement: POST Up to 4 weeks after the second measurement, the third measurement of the same variable was carried out.
Change Emotional Competences (Baseline-Pre-Post)
Time frame: Baseline up to 8 weeks
EAQ-30: This questionnaire consists of 30 Likert-style items (1-False to 3-True), and aims to identify how adolescents think about their feelings, as well as the degree to which they feel them and the ability to express them. In addition to an overall score, this tool is composed of 6 subscales that attempt to describe different aspects of emotional functioning. Higher scores indicate greater use of emotional awareness and regulation strategies. First measurement: After the participant had signed the informed consent, the initial score for this outcome was assessed. Second measurement: PRE- Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out. Third measurement: POST Up to 4 weeks after the second measurement, the third measurement of the same variable was carried out.
Change Self-concept (Baseline-Pre-Post)
Time frame: Baseline up to 8 weeks
CAG: This questionnaire aims to measure self-concept in adolescents from a multidimensional perspective. It consists of 48 Likert-type response items ranging from 1 to 5, providing a score range of 48 to 240. Physical Self-Concept, Social Acceptance, Family Self-Concept, Intellectual Self-Concept, Personal Self-Assessment, and Sense of Control. The questionnaire provides an overall self-concept score, as well as scores for 6 subdimensions: Higher scores indicate higher self-concept. This is the first measurement. After obtaining the participant's informed consent, we assessed the initial score for this outcome. The second measurement, labeled PRE, was conducted up to 4 weeks after the first measurement of the same variable. The third measurement, labeled POST, was carried out up to 4 weeks after the second measurement.
Change Coping (Baseline-Pre-Post)
Time frame: Baseline up to 8 weeks
Social Problem-Solving Inventory- Revised (SPSI-R). This questionnaire attempts to reflect the cognitive, affective and behavioral responses to the problems of daily life or the different difficulties we try to solve. This reduced version consists of 25 Likert-type items, grouped into the following 5 dimensions: Rational problem solving, Avoidant style, Impulsive style, Positive problem orientation and Negative problem orientation. Higher scores on each dimension signify the coping style used by the adolescent. First measurement: After the participant had signed the informed consent, the initial score for this outcome was assessed. Second measurement: PRE- Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out. Third measurement: POST Up to 4 weeks after the second measurement, the third measurement of the same variable was carried out.
Change Social Skills (Baseline-Pre-Post)
Time frame: Baseline up to 8 weeks
CHASO: It consists of 40 Likert-type response items ranging from 1 to 5 (1 - Very uncharacteristic of me; 5 - Very characteristic of me) and assesses a total of 10 skills: 1. Interacting with strangers; 2. Dealing with criticism; 4. Interacting with people I am attracted to; 5. Staying calm in the face of criticism; 6. Public speaking/interacting with superiors; 7. The scores for each of these skills are calculated from the sum of the items that make them up. Higher scores indicate higher social skills. First measurement: After the participant had signed the informed consent, the initial score for this outcome was assessed. Second measurement: PRE- Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out. Third measurement: POST Up to 4 weeks after the second measurement, the third measurement of the same variablewas carried out.
5 secondary outcomes
Change in Perception of Threat of disease(Baseline-Pre-Post)
Time frame: Baseline up to 8 weeks
Change Psychoeducation Diabetes
Time frame: Start of the intervetion and during it.
Change Resilience (Baseline-Pre-Post)
Time frame: Baseline up to 8 weeks
Outcome Measure: Change in Perceived Importance of Health Habits (Baseline-Pre-Post)
Time frame: Baseline up to 8 weeks
Outcome Measure: Assessment of the intervention and change in the emotional state of the participants
Time frame: Baseline up to 8 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 May 2026.
- Individual participant dataSharing planned: No
Related trials for Type 1 Diabetes
Not yet recruitingPhase 3
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Obesity, Overweight
RecruitingPhase 1
Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
Melanoma
Active, not recruitingPhase 2
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
Metastatic Colorectal Cancer
Not yet recruiting
Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes
Continuous Glucose Monitoring, Type 1 Diabetes
RecruitingObservational study
Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 Diabetes
Type 1 Diabetes, Preeclampsia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Marián Pérez-Marín, PHD principal investigator
Universitat de Valencia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing EmoTIChealth in people with Type 1 Diabetes and Asthma, run by University of Valencia at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Marián Pérez-Marín, PHD (0034 9639 ext. 83392, marian.perez@uv.es), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change Quality of Life (Baseline-Pre-Post) (time frame: Baseline up to 8 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2026.